A list of puns related to "Regn Cov2"
This is the best tl;dr I could make, original reduced by 91%. (I'm a bot)
> Regeneron Pharmaceuticals, Inc. today announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail REGN-COV2 showing it reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19.
> "After months of incredibly hard work by our talented team, we are extremely gratified to see that Regeneron's antibody cocktail REGN-COV2 rapidly reduced viral load and associated symptoms in infected COVID-19 patients," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of Regeneron.
> Serological status highly correlated with baseline viral load. Seropositive patients had much lower levels of virus at baseline, and rapidly achieved viral loads approaching lowest levels quantifiable, even without treatment.
> In the untreated patients, seropositive patients had a median time to alleviation of symptoms of 7 days, compared to seronegative patients who had a median time to alleviation of symptoms of 13 days.
> Patients with increasingly higher baseline viral levels had correspondingly greater reductions in viral load at Day 7 with REGN-COV2 treatment.
> In addition to this trial in non-hospitalized patients, REGN-COV2 is currently being studied in a Phase 2/3 clinical trial for the treatment of COVID-19 in hospitalized patients, the Phase 3 open-label RECOVERY trial of hospitalized patients in the UK and a Phase 3 trial for the prevention of COVID-19 in household contacts of infected individuals.
Summary Source | FAQ | Feedback | Top keywords: patient^#1 Regeneron^#2 REGN-COV2^#3 viral^#4 trial^#5
Post found in /r/COVID19 and [/r/Coronavirus](http://np.reddit.com/r/Coronavirus/comments/j2765u/regenerons_regncov2_antibody_cocktail_reduced/
... keep reading on reddit ➡Posted 10 December 2021 | By Jeff Craven
📷
A handful of therapeutics have been approved specifically to treat COVID-19 in different countries around the world. Among those treatments are dexamethasone, Avigan (favilavir), Veklury (remdesivir), Lagevrio (molnupiravir), Xevudy (sotrovimab), Regkirona (regdanvimab), and Ronapreve (casirivimab and imdevimab). Regulators around the world have allowed additional treatments to be used on an emergency-use basis.
This tracker will be updated biweekly with the latest in developments for treatment candidates who have advanced to at least Phase 1 study. If you notice an issue with this data or wish to submit an update, please email Regulatory Focus at news@raps.org.
Updated 10 December with new information about Lagevrio (molnupiravir), Evusheld, Regkirona, Actemra/RoActemra, amubarvimab/romlusevimab, heparin, Vascepa, Paxlovid, Xevudy, bamlanivimab + etesevimab, lenzilumab, and convalescent plasma. Please note this will be the last update of the Regulatory Focus COVID-19 therapeutics tracker for 2021. Our next update will be published on 7 January 2022.
SHOW/HIDE STUDY DESIGN & DETAILS Show 102550100 entriesSearch:Medication classTrade name (generic name)Developer/ResearcherSponsorTrial PhaseLast updateAntiviralMolnupiravir (Lagevrio, formerly known as MK-4482 and EIDD-2801)Ridgeback Biotherapeutics; MerckRidgeback Biotherapeutics; MerckPhase 310-Dec-2021Monoclonal antibodyEvusheld (tixagevimab and cilgavimab; AZD7442)AstraZeneca; Vanderbilt University Medical CenterAstraZeneca; BARDAPhase 310-Dec-2021Monoclonal antibodyRegkirona (regdanvimab, CT-P59)CelltrionCelltrionPhase 310-Dec-2021IL-6 receptor agonistActemra/RoActemra (tocilizumab)RocheVariousPhase 310-Dec-2021Monoclonal antibodyAmubarvimab and romlusevimab (formerly BRII-196 and BRII-198)Brii Biosciences LimitedNIAIDPhase 310-Dec-2021AnticoagulantHeparin (UF and LMW)NHLBIOperation Warp Speed; University of PittsburghPhase 2/3/410-Dec-2021Lipid-lowering agentVascepa (icosapent ethyl)[Amarin Corporation](https://amarinco
... keep reading on reddit ➡There's very little information about this available anywhere, but the UK government have published the supply agreement (direct link) to purchase an unknown number of doses of Roche and Regeneron's antibody treatment for COVID-19.
Obviously all the juicy bits are redacted, so we'll probably have to hope for an official announcements for any more information.
Please note that this site uses cookies to personalise content and adverts, to provide social media features, and to analyse web traffic. Click here for more information.